
Centrifuge has integrated Symbiotic’s Liquid Lane to provide immediate USDC liquidity for three of its tokenized funds, representing approximately $1.6 billion in assets under management. The integration covers Janus Henderson’s JAAA AAA-rated collateralized loan obligation strategy and JTRSY short-duration US Treasury strategy, alongside New York Life Investment Management’s HYB high-yield corporate bond strategy. Symbiotic’s Liquid Lane utilizes an onchain request-for-quote marketplace, allowing market makers to fill redemption requests by tapping into liquidity vaults. This mechanism enables investors to receive USDC instantly, decoupling the payout from the standard fund redemption timeline. By aggregating redemption demand across multiple issuers and asset classes, the platform aims to improve the economics for market makers who have historically faced low trading volumes. This development marks a significant step in enhancing the secondary market liquidity for institutional-grade tokenized assets. As tokenized funds increasingly serve as collateral in onchain markets, such infrastructure improvements are essential for broader adoption and capital efficiency.
Centrifuge is a decentralized platform designed for the tokenization of real-world assets, enabling asset managers to issue and manage funds on-chain. It bridges traditional financial products, such as Treasury bills and corporate bonds, with decentralized finance protocols to provide institutional investors with on-chain exposure. Symbiotic is a shared security and liquidity network that facilitates capital efficiency across various decentralized applications.